No­var­tis sues over IRA ahead of En­tresto price ne­go­ti­a­tions

Last year
Pharma
Law

Lung can­cer bio­mark­er cam­paign, launched with As­traZeneca, boosts its reach and adds phar­ma sup­port­ers

Last year
Pharma
Marketing

Macro­Gen­ics gets $15M from Gilead; Zenas, Bris­tol My­ers sign li­cens­ing deal in Asia-Pa­cif­ic

Last year
News Briefing

Bio­Car­dia un­veils in­ter­im da­ta that led it to stop PhI­II en­roll­ment of heart fail­ure stem cell ther­a­py

Last year
R&D
Cell/Gene Tx

Ole­ma On­col­o­gy re­ceives $180M in to­tal fund­ing

Last year
Financing
R&D

Tiv­dak gets pri­ma­ry end­point in PhI­II con­fir­ma­to­ry study

Last year
R&D

Mar­ket­ingRx roundup: No­vavax pro­motes vac­cines on Tik­Tok; BIO read­ies for fall pod­cast sea­son

Last year
Pharma
Marketing

Il­lu­mi­na names for­mer Ag­i­lent ex­ec as CEO, months af­ter part­ing ways with deS­ouza

Last year
People
Diagnostics

Beam dos­es first pa­tient with base-edit­ed cell ther­a­py

Last year
R&D
Cell/Gene Tx

First RNA edit­ing ther­a­py nears clin­ic, as Wave ask reg­u­la­tors to green­light hu­man tests

Last year
R&D

Bio­gen se­cures $1.5B loan to fund Rea­ta buy­out, with three-year re­pay­ment sched­ule baked in

Last year
Financing
Deals

Pri­vate eq­ui­ty firm Per­mi­ra buys phar­ma ser­vice provider Er­gomed in £703.1M deal

Last year
Deals

Stars align as ex-True North team nabs an­oth­er $90M to build out biotech con­stel­la­tion

Last year
Financing
Startups

For­mer Al­lo­gene CFO Er­ic Schmidt talks about his new role at Can­tor and the fu­ture of cell ther­a­pies

Last year
People
Cell/Gene Tx

Fall­out from failed MEI merg­er con­tin­ues as In­fin­i­ty's CEO, CMO ex­it

Last year
People

The ne­go­ti­a­tions list is here; Am­gen, Hori­zon clear FTC hur­dle; Fall biotech IPOs?; No­vo buys biotech part­ner in ...

Last year
Weekly

Bay­er ex­pands Keren­dia heart fail­ure pro­gram to 15,000 pa­tients as it plans to start three Phase III tri­als

Last year
R&D
Pharma

GSK in­vests $270M in­to vac­cine man­u­fac­tur­ing in Bel­gium

Last year
Pharma
Manufacturing

FDA of­fers clar­i­ty on post-warn­ing let­ter meet­ings in new draft guid­ance

Last year
Pharma
FDA+

EMA safe­ty com­mit­tee ramps up warn­ing against use of top­i­ra­mate dur­ing preg­nan­cy

Last year
Pharma
FDA+

Phar­ma and health­care spend­ing ex­pect­ed to help push ad in­dus­try to first-ever $1T to­tal in 2024, study says

Last year
Pharma
Marketing

Glob­al threat of an­tibi­ot­ic re­sis­tance high­light­ed in new film sup­port­ed by Pfiz­er, MSD, Sh­iono­gi and AMR Ac­tion Fund

Last year
Pharma
Marketing

Wal­greens CEO Ros­alind Brew­er is leav­ing the phar­ma­cy gi­ant af­ter 2.5 years

Last year
People
Health Tech

Roche says Ale­cen­sa helps keep ALK-pos­i­tive lung can­cer at bay af­ter surgery as it looks to ex­pand la­bel

Last year
R&D
First page Previous page 286287288289290291292 Next page Last page
A service from the Financial Times